You are not authorized to access this page.
Search Within

Aaron Philip Mitchell

Formats
  1. Journal Article (32)
  2. Meeting Abstract (21)
  3. Editorial (5)
  4. Correspondence (2)
  5. Research Letter (2)
  6. Review (2)
Groups
  1. Department of Medicine (64)
  2. Epidemiology and Biostatistics (64)
  3. Genitourinary Oncology Service (64)
  4. Health Outcomes Research Group (64)
  5. Population Sciences Research Program (64)
  6. Solid Tumor Oncology Division (64)

More Groups

People
  1. Peter Bach (16)
  2. Akriti Mishra (12)
  3. Sonia Persaud (10)
  4. Michael Morris (7)
  5. Nirjhar Chakraborty (6)
  6. Niti Trivedi (6)

More People

Years
  1. 2025 (6)
  2. 2024 (20)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Journal of the National Comprehensive Cancer Network (5)
  3. The Oncologist (5)
  4. JAMA Network Open (3)
  5. JNCI: Journal of the National Cancer Institute (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Oxford University Press (12)
  3. American Medical Association (5)
  4. Harborside Press (5)
  5. BMJ Publishing Group Ltd. (4)
  6. Elsevier Inc. (3)

More Publishers

Results (64)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Commercial vs. Medicaid insurance and use of high-priced anticancer treatments
    Meeting Abstract

    Mitchell, A. P.; Kinlaw, A. C.; Peacock Hinton, S.; Dusetzina, S. B.; Sanoff, H. K.; Lund, J. L.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical practice guideline descriptions of oncologic drugs granted FDA accelerated approval: A cross-sectional study
    Meeting Abstract

    Mooghali, M.; Wallach, J. D; Mitchell, A. P.; Skydel, J. J.; Ross, J. S.; Ramachandran, R.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The cancer premium – Explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: A cross sectional study
    Journal Article

    Serra-Burriel, M.; Perényi, G.; Laube, Y.; Mitchell, A. P.; Vokinger, K. N.
    eClinicalMedicine (2023)

    Fulltext@MSK | Save
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Barriers to guideline-concordant use of bone modifying agents for prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Persaud, S.; Chimonas, S.; Salner, A. L.; Palyca, P.; Farooki, A.; Ostroff, J. S.; Morris, M. J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Cost savings and increased access with ultra-low-dose immunotherapy
    Editorial

    Mitchell, A. P.; Goldstein, D. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Market determinants of commercial prices for intravenous chemotherapy infusions
    Meeting Abstract

    Milligan, M.; Orav, E. J.; Mitchell, A. P.; Lam, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pharmaceutical industry payments to physicians for the promotion of cancer drugs
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Trivedi, N. U.; Bach, P. B.; Gonen, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Industry payments to physicians are kickbacks. How should stakeholders respond?
    Journal Article

    Mitchell, A.; Sarpatwari, A.; Bach, P. B.
    Journal of Health Politics, Policy & Law (2022)

    Fulltext@MSK | Save
  • Prophylactic radiation therapy vs. standard-of-care for patients with high-risk, asymptomatic bone metastases: A multicenter, randomized phase II trial
    Meeting Abstract

    Gillespie, E. F.; Mathis, N. J.; Marine, C.; Zhang, Z.; Barker, C. A.; Guttmann, D. M.; Kotecha, R.; McIntosh, A. F.; Vaynrub, M.; Bartelstein, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save